Public Policy Letters, Statements, Legal Briefs, & Other Responses
-
Group Letter to Congress Supporting the Newborn Screening Saves Lives Reauthorization Act (NBSSLRA) of 2019
-
ACMG Comments to CMS Regarding NCD 90.2 and Medicare Coverage of NGS for Advanced Cancer
-
Group Sign-on Letter to CMS Requesting Extension of Comment Period Regarding NGS Coverage Reconsideration
-
ACMG Comments to Congress Concerning the Verifying Accurate Leading-edge IVCT Development (VALID) Act Discussion Draft
-
Group Sign-on Letter to CMS Requesting Revision of Interpretation of NCD for NGS for Advanced Cancer
-
ACMG Letter to Congress Regarding the Advancing Access to Precision Medicine Act
-
Group Sign-on Letter to Congress (Senate) Requesting FY 2019 Appropriations for Newborn Screening Programs
-
ACMG Letter to Congress Concerning the FDA Technical Assistance for the Diagnostic Accuracy and Innovation Act (DAIA)
-
Group Sign-on Letter to Congress (House) Requesting FY 2019 Appropriations for Newborn Screening Programs
-
Group Sign-on Letter to Congress Concerning the Diagnostic Accuracy and Innovation Act (DAIA)